ProCE Banner Activity

Beyond Basics in Atopic Dermatitis Care: Are You Behind the Curve With Advanced Biologics for Moderate to Severe Disease?

PDF

A checklist designed to integrate with EMR systems (where compatibility exists) and assist bedside treatment decision-making.

Released: April 18, 2025

Expiration: April 17, 2026

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

National Eczema Association

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Disclosure

Primary Author

Daniel C. Butler, MD: consultant/advisor/speaker: Galderma, Leo, Sanofi.

Peter Lio, MD, FAAD: consultant/advisor/speaker: AbbVie, Almirall, Alphyn Biologics, Amyris, Arcutis, Bristol Myers Squibb, Codex Labs, Concerto Biosciences, Dermavant, Eli Lilly, Galderma, Hyphens Pharma, Incyte, Janssen, La Roche-Posay/L'Óreal, LEO Pharma, Micreos, MyOR Diagnostics, Pelthos Therapeutics, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Skinfix, Soteri Skin, Stratum Biosciences, Thimble Health, UCB, Verdant Scientific, Verrica, Yobee Care; individually publicly traded stocks/stock options: Alphyn Biologics, Codex Labs, Concerto Biosciences, Soteri Skin, Stratum Biosciences, Thimble, Verdant Scientific, Yobee Care; royalties/patent beneficiary: Theraplex AIM (patent pending).

Benjamin Ungar, MD: consultant/advisor/speaker: AbbVie, Botanix, Bristol Myers Squibb, Fresenius Kabi, Galderma, Johnson & Johnson, LEO Pharma, Lilly, Pfizer, Primus, Sanofi, UCB; researcher: Incyte, Rapt Therapeutics, Sanofi.